Latest news on Laboratorytalk categorised by supplier
Lab21
Address:
2 Troon House 4400 Parkway
Whiteley
PO15 7FG
UK
Telephone: (0) 1489 898600;
http://www.lab21.com
Our RSS feed for news from Lab21
Request to receive our free email newsletter each week
Listing of all 17 news releases from Lab21:
Lab21 acquires NPTech
Lab21, a provider of health and environmental diagnostics, has acquired NPTech, an independent clinical laboratory providing diagnostic testing services for the NHS and private healthcare providers
News from Lab21 (26 March 2008)
Predictive genetic test for bowel cancer
Amgen UK and Lab21 have announced a partnership to introduce a new genetic therapy test for advanced bowel cancer treatment in the UK
News from Lab21 (18 March 2008)
First diagnostic tests for cirrhosis risk in hep C
Technical background article Lab21 has obtained a licence from Celera to provide access to its test for cirrhosis risk in patients with chronic hepatitis C viral (HCV) infection in the UK and Ireland
News from Lab21 (22 February 2008)
Cancer gene testing service launched by Lab21
Lab21, a provider of health and environmental diagnostics, is providing a test for analysis of the K-ras gene from its Cambridge laboratories
News from Lab21 (25 January 2008)
Diagnostic assays for healthcare and environment
Following the appointment of CEO Graham Mullis, Lab 21 is focusing its products and services under two key areas: healthcare diagnostics including personalised medicine; and environmental diagnostics
News from Lab21 (21 January 2008)
Predictive diagnostic for coronary heart disease
The oxidised low density lipoprotein (oxLDL) diagnostic test is expected to radically alter the clinical diagnosis of heart attacks in the emergency room setting
News from Lab21 (12 October 2007)
HIV Trofile assay now available in the UK
Agreement sees Lab21 provide operations and logistic services for the assay, which is a companion diagnostic used in the patient selection process for Pfizer's new antiretroviral treatment Celsentri
News from Lab21 ( 5 October 2007)
New syphilis test speeds diagnosis
Newmarket Laboratories, part of the Lab21 Group, has developed a new diagnostic test for syphilis that is rapid, accurate and easy to use
News from Lab21 (15 August 2007)
Thrombotic disease tests 'could save lives'
These thrombotic tests build on Lab21's portfolio of diagnostics for personalised medicine, adding to tests for heart disease, liver disease, cystic fibrosis and Sids (sudden infant death syndrome)
News from Lab21 (25 June 2007)
Cardiac channelopathy genetic tests in UK, Ireland
Lab21 to market and sell Clinical Data's Familion, a genetic test designed to identify mutations in people with inherited cardiac channelopathies such as Long QT Syndrome (LQTS) and Brugada Syndrome
News from Lab21 (13 December 2006)
First UK outlet for respiratory virus assay
Lab 21 announces the launch of a revolutionary new assay able to detect any virus from a panel of 20 distinct respiratory viruses using multiplex detection technology
News from Lab21 (13 December 2006)
Presentation covers alternative to liver biopsy
CD-based audiovisual presentation supports launch of liver disease assessment service and provides an overview of liver disease assessment and why it is time to review the role of liver biopsy
News from Lab21 (18 November 2005)
Team strengthened by new appointment
Pharmacogenetics specialis Lab21 has appointed Stephen Mathews to head up its pharmaceutical and biotech business development team
News from Lab21 (18 November 2005)
Deal covers hepatitis C diagnostics
Lab 21 has completed an agreement to exclusively license the hepatitis C (HCV) diagnostic technology and associated patent applications of Dr Carol Holland
News from Lab21 (21 October 2005)
Arsenic and chrome monitoring performance improved
On-line continuous batch monitoring of environmentally significant heavy metals can be used in the field, in the laboratory, or for process control
News from Lab21 ( 3 October 2005)
Liver disease assessment service is 'breakthrough'
System substitutes for biopsy by using surrogate markers of liver disease that can be measured using simple blood tests
News from Lab21 (17 August 2005)
Antiviral drug discovery and clinical trials
Array of spearhead tests and services available include lead identification and optimisation, resistance profiling, clinical candidate selection and selectivity evaluation in pre-clinical situations
News from Lab21 (26 July 2005)
